Nano Diagnostics
Nano Diagnostics is a San Jose, California-based biotechnology LLC focused on developing diagnostic products for pathogen detection. Founded in 2004, the privately held firm operates with 1-10 employees from a single headquarters and maintains an informational web presence without disclosed products, customers, or revenue mechanics.
- Company typePrivate
- Founded2004
- HeadquartersSan Jose, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nano Diagnostics does
Nano Diagnostics is a privately held biotechnology company organized as Nano Diagnostics, LLC under California jurisdiction and headquartered at 1751 Fortune Drive, unit G3, San Jose, California. The company's stated focus is developing diagnostic products for pathogen detection, placing it within the in-vitro diagnostics / clinical microbiology segment of the life sciences industry. It was founded in 2004 and operates from a single San Jose location, with no additional offices, subsidiaries, or parent-company structure disclosed.
The firm's digital surface area is minimal: a corporate website at nanodiaincs.com with a homepage, a products page, and a contact line. The products page exists but the product catalog table is empty, displaying "No Data" rather than enumerated SKUs, catalog numbers, or technical descriptions. No underlying diagnostic platform architecture, assay chemistry, instrumentation, regulatory filings (e.g., FDA 510(k), CE-IVD), patents, certifications, or technology integrations are disclosed in the available source material. There is no evidence of API exposure, SDK distribution, or third-party integrations.
The business model is not articulated in available sources. No pricing model, go-to-market channels, distribution arrangements, named customers, or revenue mechanics are disclosed. Workforce is reported at 1-10 employees, no management team or leadership roster is published, and there are no funding rounds, investors, or M&A activity on record. The only verifiable signal of recent activity is a news post on the company website dated June 29, 2026, the content of which is not fully captured, indicating continued but low-velocity operations rather than active commercial scaling.
Nano Diagnostics firmographics
Firmographics- Name
- Nano Diagnostics
- Legal name
- Nano Diagnostics, LLC
- Website
- https://nanodiaincs.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Nano Diagnostics is a San Jose, California-based biotechnology LLC focused on developing diagnostic products for pathogen detection. Founded in 2004, the privately held firm operates with 1-10 employees from a single headquarters and maintains an informational web presence without disclosed products, customers, or revenue mechanics.
- Ownership category
- akta.pro rank
Nano Diagnostics industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Nanotechnology (541713)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)
- akta.pro secondary industries
- Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
Keywords
Where Nano Diagnostics is headquartered
LocationHeadquarters
- HQ city
- San Jose
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Nano Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations
Nano Diagnostics product offering
Product offeringCore offering
Nano Diagnostics is a biotechnology company that develops diagnostic products aimed at pathogen detection. The company operates a small-scale operation focused on providing diagnostic solutions to its customers. Specific product catalog items are not enumerated on the company's website at this time.
Product overview
Nano Diagnostics appears to offer diagnostic products or services, though the specific product portfolio is not enumerated in the available source material. The company's products page exists at https://www.nanodiaincs.com/products but displays no product listings in the scraped content.
Differentiator
Problem solved
Functional benefit
Companies that use Nano Diagnostics
Customer profileIdeal customer profiles1 record
Nano Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Nano Diagnostics partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
Nano Diagnostics competitors and assessment
Company assessmentBroad incumbents
- Cepheid (Danaher): Cepheid, owned by Danaher, pioneered the GeneXpert molecular diagnostics platform widely used for pathogen detection including tuberculosis, MRSA, and respiratory pathogens. Directly comparable in pathogen-detection molecular diagnostics at a much larger commercial scale.
- Hologic: Hologic's Panther system and Panther Fusion offer molecular diagnostics for women's health and infectious disease pathogens. Comparable as a diagnostics incumbent serving clinical laboratories with pathogen-detection products.
- BioFire Diagnostics (bioMérieux): BioFire, a subsidiary of bioMérieux, is a leader in molecular diagnostics for pathogen detection with its FilmArray system widely used in clinical labs. Directly comparable as a pathogen-detection diagnostics company, though vastly larger and more established than Nano Diagnostics.
- GenMark Diagnostics (Roche): GenMark, now part of Roche, develops multiplex molecular diagnostic tests for respiratory pathogens and bloodstream infections using its ePlex system. Closely comparable in multiplex pathogen detection diagnostics.
- QIAGEN: QIAGEN is a major molecular diagnostics and sample technologies company with broad pathogen-detection offerings including the QIAstat-Dx system. Relevant as a broad incumbent in the molecular diagnostics space that includes pathogen detection.
Emerging players
- T2 Biosystems: T2 Biosystems develops molecular diagnostics using T2 Magnetic Resonance (T2MR) technology for direct-from-blood pathogen detection. Comparable as a smaller-scale pathogen-detection diagnostics company, with somewhat similar operational scale challenges.
- Mesa Labs: Mesa Labs offers diagnostics and quality control products across multiple niches including clinical microbiology. Somewhat comparable as a smaller-scale diagnostics company serving laboratory and clinical customers.
- Binx Health: Binx Health provides rapid molecular point-of-care diagnostics, including for sexually transmitted infections. Comparable as a smaller molecular diagnostics player developing rapid pathogen-detection products, somewhat similar in scale and stage.
- Specific Diagnostics: Specific Diagnostics develops rapid antimicrobial susceptibility testing and pathogen identification products using metabolomic signatures. Comparable as a smaller-scale, growth-stage molecular diagnostics company focused on infectious disease.
- Accelerate Diagnostics: Accelerate Diagnostics provides rapid pathogen identification and antimicrobial susceptibility testing, including the Accelerate Pheno system. Comparable as a small-to-mid scale pathogen diagnostics player focused on clinical microbiology.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks6 records
Key highlights3 records
Customer concentration
Nano Diagnostics social profiles
Digital presenceNano Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nano Diagnostics leadership team
Management profileNumber of profiles
Nano Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nano Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nano Diagnostics
What does Nano Diagnostics do?
Nano Diagnostics is a biotechnology company that develops diagnostic products aimed at pathogen detection. The company operates a small-scale operation focused on providing diagnostic solutions to its customers. Specific product catalog items are not enumerated on the company's website at this time.
Is Nano Diagnostics a public or private company?
Nano Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Nano Diagnostics founded?
Nano Diagnostics was founded in 2004. It employs 1 to 10 people.
Where is Nano Diagnostics based?
Nano Diagnostics is headquartered in San Jose, United States, in the North America region.
Who are Nano Diagnostics's main competitors?
Broad incumbents on record are Cepheid (Danaher), Hologic, BioFire Diagnostics (bioMérieux), GenMark Diagnostics (Roche) and QIAGEN. Emerging players are T2 Biosystems, Mesa Labs, Binx Health, Specific Diagnostics and Accelerate Diagnostics.
Does Nano Diagnostics have an API?
No public API is recorded for Nano Diagnostics.
What industry is Nano Diagnostics in?
Nano Diagnostics's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays), with a secondary code of HDAHALAK, Biosensors & Lab-on-Chip (BioMEMS). Its NAICS code is 325413 and its SIC code is 2835.